Research Article

You have open access to this content

Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene

  1. Shyra J. Miller1,†,
  2. Walter J. Jessen2,†,
  3. Tapan Mehta4,
  4. Atira Hardiman1,
  5. Emily Sites1,
  6. Sergio Kaiser2,3,
  7. Anil G. Jegga2,
  8. Hua Li5,
  9. Meena Upadhyaya6,
  10. Marco Giovannini7,8,
  11. David Muir9,
  12. Margaret R. Wallace5,
  13. Eva Lopez10,
  14. Eduard Serra10,
  15. G. Petur Nielsen11,
  16. Conxi Lazaro10,
  17. Anat Stemmer-Rachamimov11,
  18. Grier Page4,
  19. Bruce J. Aronow2,
  20. Nancy Ratner1,*

Article first published online: 10 JUL 2009

DOI: 10.1002/emmm.200900027

Issue

EMBO Molecular Medicine

EMBO Molecular Medicine

Volume 1, Issue 4, pages 236–248, July 2009

Additional Information

How to Cite

Miller, S. J., Jessen, W. J., Mehta, T., Hardiman, A., Sites, E., Kaiser, S., Jegga, A. G., Li, H., Upadhyaya, M., Giovannini, M., Muir, D., Wallace, M. R., Lopez, E., Serra, E., Nielsen, G. P., Lazaro, C., Stemmer-Rachamimov, A., Page, G., Aronow, B. J. and Ratner, N. (2009), Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. EMBO Mol Med, 1: 236–248. doi: 10.1002/emmm.200900027

Author Information

  1. 1

    Divisions of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital, University of Cincinnati College of Medicine, Cincinnati, OH, USA

  2. 2

    Divisions of Biomedical Informatics, Cincinnati Children's Hospital Research Foundation, University of Cincinnati College of Medicine, Cincinnati, OH, USA

  3. 3

    Present address: Novartis Pharma AG, Basel, Switzerland

  4. 4

    Department of Biostatistics, Section on Statistical Genetics, University of Alabama at Birmingham, Birmingham, AL, USA

  5. 5

    Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, FL, USA

  6. 6

    Institute of Medical Genetics, University of Wales College of Medicine, Heath Park, Cardiff CF, UK

  7. 7

    INSERM U434, Foundation Jean Dausset-CEPH, Paris, France

  8. 8

    Present address: House Ear Institute, Department of Neural Tumor Research, Los Angeles, CA, USA

  9. 9

    Departments of Pediatrics and Neuroscience, University of Florida, Gainesville, FL, USA

  10. 10

    Centre de Genètica Mèdica i Molecular (EL and ES), Laboratori de Recerca Translacional, Institut Català d'Oncologia (CL); Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain

  11. 11

    Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA

  1. †

    Contributed equally to this work.

*Tel: +1 513 636 9469; Fax: +1 513 636 3549

Publication History

  1. Issue published online: 10 JUL 2009
  2. Article first published online: 10 JUL 2009
  3. Manuscript Accepted: 5 JUN 2009
  4. Manuscript Received: 18 DEC 2008

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (815K)

References

  • Ars E, Serra E, Garcia J, Kruyer H, Gaona A, Lazaro C, Estivill X (2000) Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. Hum Mol Genet 9: 237- 247
  • Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I (2001) Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125: 279- 284
  • Britsch S, Goerich DE, Riethmacher D, Peirano RI, Rossner M, Nave KA, Birchmeier C, Wegner M (2001) The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev 15: 66- 78
  • Buchstaller J, Sommer L, Bodmer M, Hoffmann R, Suter U, Mantei N (2004) Efficient isolation and gene expression profiling of small numbers of neural crest stem cells and developing Schwann cells. J Neurosci 24: 2357- 2365
  • Carroll SL, Ratner N (2008) How does the Schwann cell lineage form tumors in NF1? Glia 56: 1590- 1605
    Direct Link:
  • Casella GT, Bunge RP, Wood PM (1996) Improved method for harvesting human Schwann cells from mature peripheral nerve and expansion in vitro. Glia 17: 327- 338
    Direct Link:
  • Cheung M, Chaboissier MC, Mynett A, Hirst E, Schedl A, Briscoe J (2005) The transcriptional control of trunk neural crest induction, survival, and delamination. Dev Cell 8: 179- 192
  • Cichowski K, Jacks T (2001) NF1 tumor suppressor gene function: narrowing the GAP. Cell 104: 593- 604
  • Dai M, Wang P, Boyd AD, Kostov G, Athey B, Jones EG, Bunney WE, Myers RM, Speed TP, Akil H, et al. (2005) Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res 33: e175
  • DeClue JE, Heffelfinger S, Benvenuto G, Ling B, Li S, Rui W, Vass WC, Viskochil D, Ratner N (2000) Epidermal growth factor receptor expression in neurofibromatosis type 1-related tumors and NF1 animal models. J Clin Invest 105: 1233- 1241
  • Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A (2002) Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 39: 311- 314
  • Garraway LA, Sellers WR (2006) Lineage dependency and lineage-survival oncogenes in human cancer. Nat Rev Cancer 6: 593- 602
  • Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, Rubenstein A, Viskochil D (1997) The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278: 51- 57
  • Holtkamp N, Reuss DE, Atallah I, Kuban RJ, Hartmann C, Mautner VF, Frahm S, Friedrich RE, Algermissen B, Pham VA, et al. (2004) Subclassification of nerve sheath tumors by gene expression profiling. Brain Pathol 14: 258- 264
    Direct Link:
  • Huang da W, Sherman BT, Tan Q, Collins JR, Alvord WG, Roayaei J, Stephens R, Baseler MW, Lane HC, Lempicki RA (2007) The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol 8: R183
  • Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249- 264
  • Jegga AG, Chen J, Gowrisankar S, Deshmukh MA, Gudivada R, Kong S, Kaimal V, Aronow BJ (2007) GenomeTrafac: a whole genome resource for the detection of transcription factor binding site clusters associated with conventional and microRNA encoding genes conserved between mouse and human gene orthologs. Nucleic Acids Res 35: D116- D121
  • Jessen KR, Mirsky R (2005) The origin and development of glial cells in peripheral nerves. Nat Rev Neurosci 6: 671- 682
  • Joseph NM, Mosher JT, Buchstaller J, Snider P, McKeever PE, Lim M, Conway SJ, Parada LF, Zhu Y, Morrison SJ (2008) The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells. Cancer Cell 13: 129- 140
  • Karube K, Nabeshima K, Ishiguro M, Harada M, Iwasaki H (2006) cDNA microarray analysis of cancer associated gene expression profiles in malignant peripheral nerve sheath tumours. J Clin Pathol 59: 160- 165
  • Kellerer S, Schreiner S, Stolt CC, Scholz S, Bosl MR, Wegner M (2006) Replacement of the Sox10 transcription factor by Sox8 reveals incomplete functional equivalence. Development 133: 2875- 2886
  • Kim K, Page GP, Beasley TM, Barnes S, Scheirer KE, Allison DB (2006) A proposed metric for assessing the measurement quality of individual microarrays. BMC Bioinformatics 7: 35
  • Kuhlbrodt K, Herbarth B, Sock E, Hermans-Borgmeyer I, Wegner M (1998) Sox10, a novel transcriptional modulator in glial cells. J Neurosci 18: 237- 250
  • Le LQ, Parada LF (2007) Tumor microenvironment and neurofibromatosis type I: connecting the GAPs. Oncogene 26: 4609- 4616
  • Le LQ, Shipman T, Burns DK, Parada LF (2009) Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas. Cell Stem Cell 4: 453- 463
  • Levy P, Bieche I, Leroy K, Parfait B, Wechsler J, Laurendeau I, Wolkenstein P, Vidaud M, Vidaud D (2004) Molecular profiles of neurofibromatosis type 1-associated plexiform neurofibromas: identification of a gene expression signature of poor prognosis. Clin Cancer Res 10: 3763- 3771
  • Levy P, Ripoche H, Laurendeau I, Lazar V, Ortonne N, Parfait B, Leroy K, Wechsler J, Salmon I, Wolkenstein P, et al. (2007) Microarray-based identification of tenascin C and tenascin XB, genes possibly involved in tumorigenesis associated with neurofibromatosis type 1. Clin Cancer Res 13: 398- 407
  • Mantripragada KK, Spurlock G, Kluwe L, Chuzhanova N, Ferner RE, Frayling IM, Dumanski JP, Guha A, Mautner V, Upadhyaya M (2008) High-resolution DNA copy number profiling of malignant peripheral nerve sheath tumors using targeted microarray-based comparative genomic hybridization. Clin Cancer Res 14: 1015- 1024
  • Mertin S, McDowall SG, Harley VR (1999) The DNA-binding specificity of SOX9 and other SOX proteins. Nucleic Acids Res 27: 1359- 1364
  • Miller SJ, Li H, Rizvi TA, Huang Y, Johansson G, Bowersock J, Sidani A, Vitullo J, Vogel K, Parysek LM, et al. (2003) Brain lipid binding protein in axon-Schwann cell interactions and peripheral nerve tumorigenesis. Mol Cell Biol 23: 2213- 2224
  • Miller SJ, Rangwala F, Williams J, Ackerman P, Kong S, Jegga AG, Kaiser S, Aronow BJ, Frahm S, Kluwe L, et al. (2006) Large-scale molecular comparison of human schwann cells to malignant peripheral nerve sheath tumor cell lines and tissues. Cancer Res 66: 2584- 2591
  • Nowak JA, Polak L, Pasolli HA, Fuchs E (2008) Hair follicle stem cells are specified and function in early skin morphogenesis. Cell Stem Cell 3: 33- 43
  • Page GP, Edwards JW, Gadbury GL, Yelisetti P, Wang J, Trivedi P, Allison DB (2006) The PowerAtlas: a power and sample size atlas for microarray experimental design and research. BMC Bioinformatics 7: 84
  • Panda DK, Miao D, Lefebvre V, Hendy GN, Goltzman D (2001) The transcription factor SOX9 regulates cell cycle and differentiation genes in chondrocytic CFK2 cells. J Biol Chem 276: 41229- 41236
  • Paul R, Haydon RC, Cheng H, Ishikawa A, Nenadovich N, Jiang W, Zhou L, Breyer B, Feng T, Gupta P, et al. (2003) Potential use of Sox9 gene therapy for intervertebral degenerative disc disease. Spine 28: 755- 763
  • Peirano RI, Goerich DE, Riethmacher D, Wegner M (2000) Protein zero gene expression is regulated by the glial transcription factor Sox10. Mol Cell Biol 20: 3198- 3209
  • Perry A, Kunz SN, Fuller CE, Banerjee R, Marley EF, Liapis H, Watson MA, Gutmann DH (2002) Differential NF1, p16, and EGFR patterns by interphase cytogenetics (FISH) in malignant peripheral nerve sheath tumor (MPNST) and morphologically similar spindle cell neoplasms. J Neuropathol Exp Neurol 61: 702- 709
  • Persson S, Wei H, Milne J, Page GP, Somerville CR (2005) Identification of genes required for cellulose synthesis by regression analysis of public microarray data sets. Proc Natl Acad Sci USA 102: 8633- 8638
  • Powers JF, Evinger MJ, Zhi J, Picard KL, Tischler AS (2007) Pheochromocytomas in Nf1 knockout mice express a neural progenitor gene expression profile. Neuroscience 147: 928- 937
  • Rasmussen SA, Friedman JM (2000) NF1 gene and neurofibromatosis 1. Am J Epidemiol 151: 33- 40
  • Schreiner S, Cossais F, Fischer K, Scholz S, Bosl MR, Holtmann B, Sendtner M, Wegner M (2007) Hypomorphic Sox10 alleles reveal novel protein functions and unravel developmental differences in glial lineages. Development 134: 3271- 3281
  • Serra E, Rosenbaum T, Nadal M, Winner U, Ars E, Estivill X, Lazaro C (2001) Mitotic recombination effects homozygosity for NF1 germline mutations in neurofibromas. Nat Genet 28: 294- 296
  • Serra E, Rosenbaum T, Winner U, Aledo R, Ars E, Estivill X, Lenard HG, Lazaro C (2000) Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations. Hum Mol Genet 9: 3055- 3064
  • Sheela S, Riccardi VM, Ratner N (1990) Angiogenic and invasive properties of neurofibroma Schwann cells. J Cell Biol 111: 645- 653
  • Sherman LS, Atit R, Rosenbaum T, Cox AD, Ratner N (2000) Single cell Ras-GTP analysis reveals altered Ras activity in a subpopulation of neurofibroma Schwann cells but not fibroblasts. J Biol Chem 275: 30740- 30745
  • Upadhyaya M, Spurlock G, Majounie E, Griffiths S, Forrester N, Baser M, Huson SM, Gareth Evans D, Ferner R (2006) The heterogeneous nature of germline mutations in NF1 patients with malignant peripheral serve sheath tumours (MPNSTs). Hum Mutat 27: 716
    Direct Link:
  • Wallace MR, Rasmussen SA, Lim IT, Gray BA, Zori RT, Muir D (2000) Culture of cytogenetically abnormal schwann cells from benign and malignant NF1 tumors. Genes Chromosomes Cancer 27: 117- 123
    Direct Link:
  • Wei Q, Miskimins WK, Miskimins R (2004) Sox10 acts as a tissue-specific transcription factor enhancing activation of the myelin basic protein gene promoter by p27Kip1 and Sp1. J Neurosci Res 78: 796- 802
    Direct Link:
  • Williams JP, Wu J, Johansson G, Rizvi TA, Miller SC, Geiger H, Malik P, Li W, Mukouyama YS, Cancelas JA, et al. (2008) Nf1 mutation expands an EGFR-dependent peripheral nerve progenitor that confers neurofibroma tumorigenic potential. Cell Stem Cell 3: 658- 669
  • Wimmer K, Yao S, Claes K, Kehrer-Sawatzki H, Tinschert S, De Raedt T, Legius E, Callens T, Beiglbock H, Maertens O, et al. (2006) Spectrum of single- and multiexon NF1 copy number changes in a cohort of 1,100 unselected NF1 patients. Genes Chromosomes Cancer 45: 265- 276
    Direct Link:
  • Wu J, Williams JP, Rizvi TA, Kordich JJ, Witte D, Meijer D, Stemmer-Rachamimov AO, Cancelas JA, Ratner N (2008) Plexiform and dermal neurofibromas and pigmentation are caused by nf1 loss in desert hedgehog-expressing cells. Cancer Cell 13: 105- 116
  • Zhu Y, Ghosh P, Charnay P, Burns DK, Parada LF (2002) Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science 296: 920- 922
View Full Article with Supporting Information (HTML) Get PDF (815K)